switching from semaglutide to zepbound vs GLP-1: What's the Difference? transitioning from semaglutide to tirzepatide

Retatrutide is an investigational triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, producing appetite suppression, enhanced insulin secretion, and increased energy expenditure, though long-term safety and cardiovascular outcome data are not yet available

Despite these harsh conditions, cell viability and functional integrity can be prevered over extended periods under controlled conditions []

Want expert guidance

Nutrition, lifestyle, and overall health are factored into every care plan

Insulin resistance, as well as the conditions of hyperinsulinemia, hyperglycemia, and elevated free fatty acids, play a substantial role in causing injury to cardiomyocytes, deteriorating their functionality, and leading to myocardial lipotoxicity in individuals with diabetes [88]

Compounded semaglutide should never be frozen